id,report_id,created,last_updated,library,subject_data,column_variable,filter,stat_label,report_type,template,task
199,TDM001,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Demographics,Demog,0,1
198,TDM002,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Demographics,Demog,0,1
197,TDM003,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Demographics,Demog,0,1
196,TDM004,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Demographics,Demog,0,1
195,TDM005,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Demographics,Demog,0,1
194,TDS001,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Disposition,Disposition,0,1
193,TDS002,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Disposition,Disposition,0,1
192,TDS003,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Disposition,Disposition,0,1
191,TDS004,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Disposition,Disposition,0,1
190,TDS005,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Disposition,Disposition,0,1
189,TAE001,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
188,TAE002,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Serious Adverse Events,AE,0,1
187,TAE003,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Severe Adverse Events,AE,0,1
186,TAE004,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,"Grade 1, 2, 3 Adverse Events",AE,0,1
185,TAE005,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
184,TAE006,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
183,TAE007,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
182,TAE008,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
181,TAE009,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
180,TAE010,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
179,TAE011,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
178,TAE012,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
177,TAE013,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
176,TAE014,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
175,TAE015,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
174,TAE016,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
173,TAE017,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
172,TAE018,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
171,TAE019,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
170,TAE020,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
169,TAE021,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
168,TAE022,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
167,TAE023,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
166,TAE024,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
165,TAE025,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01a,1,Adverse Events,AE,0,1
164,TEF001,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
163,TEF002,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
162,TEF003,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
161,TEF004,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
160,TEF005,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
159,TEF006,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
158,TEF007,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
157,TEF008,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
156,TEF009,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
155,TEF010,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
154,TEF011,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
153,TEF012,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
152,TEF013,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
151,TEF014,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
150,TEF015,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
149,TEF016,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
148,TEF017,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
147,TEF018,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
146,TEF019,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
145,TEF020,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
144,TEF021,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
143,TEF022,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
142,TEF023,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
141,TEF024,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
140,TEF025,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
139,TEF026,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
138,TEF027,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
137,TEF028,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
136,TEF029,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
135,TEF030,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
134,TEF031,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
133,TEF032,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
132,TEF033,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
131,TEF034,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
130,TEF035,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
129,TEF036,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
128,TEF037,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
127,TEF038,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
126,TEF039,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
125,TEF040,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
124,TLB001,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Laboratory Results,Labs,0,1
123,TLB002,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Laboratory Results,Labs,0,1
122,TLB003,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Laboratory Results,Labs,0,1
121,TLB004,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Laboratory Results,Labs,0,1
120,TLB005,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Laboratory Results,Labs,0,1
119,TLB006,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Laboratory Results,Labs,0,1
118,TLB007,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Laboratory Results,Labs,0,1
117,TLB008,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Laboratory Results,Labs,0,1
116,TLB009,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Laboratory Results,Labs,0,1
115,TLB010,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Laboratory Results,Labs,0,1
114,TVS001,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Vital Signs,Vital Signs,0,1
113,TVS002,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Vital Signs,Vital Signs,0,1
112,TVS003,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Vital Signs,Vital Signs,0,1
111,TVS004,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Vital Signs,Vital Signs,0,1
110,TVS005,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Vital Signs,Vital Signs,0,1
109,TEF056,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
108,TEF057,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
107,TEF058,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
106,TEF059,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
105,TEF060,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
104,TEF061,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
103,TEF062,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
102,TEF063,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
101,TEF064,2019-04-06 05:47:16,2019-04-06 05:47:16,adam,adsl,trt01p,1,Efficacy Analysis,Efficacy,0,1
